In contrast to the control cells, treating CPI−-infected Hep2/BVDV-Npro/shISG56/IFIT1 cells with IFN either prior to or after infection did not significantly alter either the pattern or levels of virus transcript accumulation. This evidence concerns the gene IFNA1 and infection.